Myelomeningocele: A review of the epidemiology, genetics, risk factors for conception, prenatal diagnosis, and prognosis for affected individuals

Obstetrical and Gynecological Survey

Volumn 62, Issue 7, 2007, Pages 471-479

  Shaer, Catherine M ^a   Chescheir, Nancy ^b   Schulkin, Jay ^c  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c AMERICAN COLLEGE OF OBSTETRICIANS AND GYNECOLOGISTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONCEPTION; GENETICS; GYNECOLOGY; HUMAN; INFORMATION; KNOWLEDGE; MENINGOMYELOCELE; OBSTETRICS; PRENATAL DIAGNOSIS; PROGNOSIS; REVIEW; RISK FACTOR; SCREENING; SPINA BIFIDA; ECHOGRAPHY; FEMALE; NEWBORN; PREGNANCY;

FOLIC ACID;

FEMALE; FOLIC ACID; HUMANS; INFANT, NEWBORN; MENINGOMYELOCELE; PREGNANCY; PROGNOSIS; RISK FACTORS; ULTRASONOGRAPHY, PRENATAL;

EID: 34547608773     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ogx.0000268628.82123.90     Document Type: Review

References (105)

1. Sadler TW. Embryology of neural tube development. Am J Med Genet C Seminin Med Genet 2005;135:2-8.
2. O'Rahily R, Muller F. The two sites of fusion of the neural folds and the two neuropores in the human embryo. Teratology 2002;65:162-170.
3. Shaer CM, Chescheir N, Erickson K, et al. Obstetrician-gynecologists' practice and knowledge regarding spina bifida. Am J Perinatol 2006;23:355-362.
4. Seller MJ. An essay on research into the causation and prevention of spina bifida. Z Kinderchir 1981;34:306-314.
5. Smithells RW, Sheppars D, Schorah CJ, et al. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet 1980;1:339-340.
6. Abel J. Neural tube defects: British vitamin trial starts slowly. Nature 1984;309:661.
7. MRC Vitamin Study Research Group. Prevention of neural tube defects: results of the Medical Research Council vitamin study. Lancet 1991;338:131-137.
8. Centers for Disease Control. Use of folic acid for prevention of spina bifida and other neural tube defects - 1983-1991. MMWR Morb Mortal Wkly Rep 1991;40:513.
9. Van Allen MI, Fraser FC, Dallaire L, et al. Recommendations on the use of folic acid supplementation to prevent the recurrence of neural tube defects. Clinical Teratology Committee, Canadian College of Medical Geneticists. CMAJ 1993;149:1239-1243.
10. Recommendations for the use of folic acid to reduce the number of cases of spina bifida and other birth defects. MMWR Recomm Rep 1992;41(RR-14):1-7.
11. Centers for Disease Control and Prevention (CDC). Spina bifida and anencephaly before and after folic acid mandate - United States, 1995-1996 and 1999-2000. MMWR Morb Mortal Wkly Rep 2004;53:362-365.
12. Matthews TJ, Honein MA, Erickson JD. Spina bifida and anencephaly prevalence - United States, 1991-2001. MMWR Recomm Rep 2002;51(RR-13):9-11.
13. Canfield MA, Honein MA, Yuskiv N, et al. National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001. Birth Defects Res A Clin Mol Teratol 2006;76:747-756.
14. Mitchell LE. Epidemiology of neural tube defects. Am J Med Genet C Seminin Med Genet 2005;135:88-94.
15. Cragan JD, Roberts HE, Edmonds LD, et al. Surveillance for anencephaly and spina bifida and the impact of prenatal diagnosis - United States, 1985-1994. MMWR CDC Surveill Summ 1995;44:1-13.
16. Sepulveda W, Corral E, Ayala C, et al. Chromosomal abnormalities in fetuses with open neural tube defects: prenatal identification with ultrasound. Ultrasound Obstet Gynecol 2004;23:352-356.
17. Harmon JP, Hiett AK, Palmer C, et al. Prenatal ultrasound detection of isolated neural tube defects: is cytogenetic evaluation warranted? Obstet Gynecol 1995;86(4 pt 1):595-599.
18. Kennedy D, Chitayat D, Winsor EJ, et al. Prenatally diagnosed neural tube defects: ultrasound, chromosome, and autopsy or postnatal findings in 212 cases. Am J Med Genet 1998;77:317-321.
19. Hall JG, Solehdin F. Genetics of neural tube defects. Ment Retard Dev Disabil Res Rev 1998;4:269-281.
20. Coerdt W, Miller K, Holzgreve W, et al. Neural tube defects in chromosomally normal and abnormal human embryos. Ultrasound Obstet Gynecol 1997;10:410-415.
21. Hume RF, Drugan A, Reichler A, et al. Aneuploidy among prenatally detected neural tube defects. Am J Med Genet 1996;61:171-173.
22. Creasy MR, Alberman ED. Congenital malformations of the central nervous system in spontaneous abortions. J Med Genet 1976;13:9-16.
23. Lynch SA. Non-multifactorial neural tube defects. Am J Med Genet C Seminin Med Genet 2005;135:69-76.
24. Rodriguez JI, Garcia M, Morales C, et al. Trisomy 13 syndrome and neural tube defects. Am J Med Gen 1990;36:513-516.
25. Baraitser M, Burn J. Brief clinical report: neural tube defects as an X-linked condition. Am J Med Genet 1984;17:383-385.
26. Toriello HV, Higgins JV. Possible causal heterogeneity in spina bifida cystica. Am J Med Genet 1985;2:13-20.
27. Koren G. Safe use of valproic acid during pregnancy. Can Fam Physician 1999;45:1451-1453.
28. Lammer EJ, Sever LE, Oakley GP. Teratogen update: valproic acid. Teratololgy 1987;35:465-473.
29. Yerby MS. Clinical care of pregnant women with epilepsy: neural tube defects and folic acid supplementation. Epilepsia 2003;44(suppl 3):33-40.
30. Yerby MS. Management issues for women with epilepsy: neural tube defects and folic acid supplementation. Neurology 2003;61(6 suppl 2):S23-S26.
31. Werler MM, Louik C, Shapiro S, et al. Prepregnant weight in relation to risk of neural tube defects. JAMA 1996;275:1089-1092.
32. Shaw GM, Velie EM, Schaffer D. Risk of neural tube defect-affected pregnancies among obese women. JAMA 1996;275:1093-1096.
33. Shaw GM, Todoroff K, Finnell RH, et al. Spina bifida phenotypes in infants or fetuses of obese mothers. Teratology 2000;61:376-381.
34. Watkins ML, Rasmussen SA, Honein MA, et al. Maternal obesity and risk for birth defects. Pediatrics 2003;111(5 pt 2):1152-1158.
35. Chen CP. Maternal diabetes and neural tube defects: prenatal diagnosis of lumbosacral myelomeningocele, ventriculomegaly, Arnold Chiari malformation and foot deformities in a pregnancy with poor maternal metabolic control and review of the literature. Genet Couns 2005;16:313-316.
36. Anderson JL, Waller DK, Canfield MA, et al. Maternal obesity, gestational diabetes, and central nervous system birth defects. Epidemiology 2005;16:87-92.
37. Suarez L, Felkner M, Hendricks K. The effect of fever, febrile illnesses, and heat exposures on the risk of neural tube defects in a Texas-Mexico border population. Birth Defects Res A Clin Mol Teratol 2004;70:815-819.
38. Shaw GM, Nelson V, Todoroff K, et al. Maternal periconceptional use of electric bed-heating devices and risk for neural tube defects and orofacial clefts. Teratology 1999;60:124-129.
39. Peadar KN, Mills JL, Brody LC, et al. Impact of the MTHFR C677T polymorphism on risk of neural tube defects: case control study. BMJ 2004;328:1535-1536.
40. Botto LD, Quanhe Y. 5,10-Methylenetetrahydrofolate reductase (MTHFR) gene variants and congenital anomalies. Am J Epidemiol 2000;151:862-877.
41. De Marco P, Calevo MG, Moroni A, et al. Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J Hum Genet 2002;47:319-324.
42. Martinez de Villarreal LE, Delgado-Encisco I, Valdez-Leal R, et al. Folate levels and N(5), N(10)-methylenetetrahydrofolate reductase genotype (MTHFR) in mothers of offspring with neural tube defects: a case control study. Arch Med Res 2001;32:277-282.
43. Wilson A, Platt R, Wu Q, et al. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab 1999;67:317-323.
44. van der Linden IJ, den Heijer M, Afman LA, et al. The methionine synthase reductase 66A > G polymorphism is a maternal risk factor for spina bifida. J Mol Med 2006;84:1047-1054.
45. Carsin A, Journel H, Roussey M, et al. Incidence of occult lumbo-sacral spina bifida in parents of children with spina bifida (concerning 80 pairs with affected children). J Genet Hum 1986;34:285-292.
46. Gregerson DM. Clinical consequences of spina bifida occulta. J Manipulative Physiol Ther 1997;20:546-550.
47. Boone D, Parsons D, Lachmann SM, et al. Spina bifida occulta: lesion or anomaly? Clin Radiol 1985;36:159-161.
48. Taskaynatan MA, Izci Y, Ozgul A, et al. Clinical significance of congenital lumbosacral malformations in young male population with prolonged back pain. Spine 2005;30:E210-E213.
49. Norem CT, Schoen EJ, Walton DL, et al. Routine ultrasonography compared with maternal serum alpha-fetoprotein for neural tube defect screening. Obstet Gynecol 2005;106:747-752.
50. Loft AG, Hogdall E, Larsen SO, et al. A comparison of amniotic fluid alpha-fetoprotein and acetylcholinesterase in the prenatal diagnosis of open neural tube defects and anterior abdominal wall defects. Prenat Diagn 1993;13:93-109.
51. Blumenfeld Z, Siegler E, Bronshtein M. The early diagnosis of neural tube defects. Prenat Diagn 1993;13:863-871.
52. Van den Hof MC, Nicolaides KH, Campbell J, et al. Evaluation of the lemon and banana signs in one hundred thirty fetuses with open spina bifida. Am J Obstet Gynecol 1990;162:322-327.
53. Campbell J, Gilbert WM, Nicolaides KH, et al. Ultrasound screening for spina bifida: cranial and cerebellar signs in a high-risk population. Obstet Gynecol 1987;70:247-250.
54. Thiagarajah S, Henke J, Hogge WA, et al. Early diagnosis of spina bifida: the value of cranial ultrasound markers. Obstet Gynecol 1990;76:54-57.
55. Ball RH, Filly RA, Goldstein RB, et al. The lemon sign: not a specific indicator of myelomeningocele. J Ultrasound Med 1993;12:131-134.
56. Tortori-Donati P, Rossi A, Cama A. Spinal dysraphism: a review of neuroradiological features with embryological correlations and proposal for a new classification. Neuroradiology 2000;42:471-491.
57. Ramin KD, Raffel C, Breckle RJ, et al. Chronology of neurological manifestations of prenatally diagnosed open neural tube defects. J Matern Fetal Neonatal Med 2002;11:89-92.
58. Wong LY, Paulozzi LJ. Survival of infants with spina bifida: a population study, 1979-94. Paediatri Perinat Epidemiol 2001;15:374-378.
59. McLone DG. Results of treatment of children born with myelomeningocele. Clin Neurosurg 1983;30:407-412.
60. Bowman RM, McLone DG, Grant JA, et al. Spina bifida outcome: a 25-year perspective. Pediatr Neurosurg 2001;34:114-120.
61. Hunt GM, Oakeshott P. Lifestyle in adults aged 35 years who were born with open spina bifida: prospective cohort study. Cerebrospinal Fluid Res 2004;1:4.
62. Davis BE, Daley CM, Shurtleff DB, et al. Long-term survival of individuals with myelomeningocele. Pediatr Neurosurg 2005;41:186-191.
63. Lapides J, Diokno AC, Silber SJ, et al. Clean intermittent catheterization in the treatment of urinary tract disease. J Urol 1972;107:458-461.
64. Stevenson KL. Chiari Type II malformation: past, present, and future. Neurosurg Focus 2004;16:E5.
65. Tuli S, Tuli J, Drake J, et al. Predictors of death in pediatric patients requiring cerebrospinal fluid shunts. J Neurosurg 2004;100(Pediatrics 5):442-446.
66. Tomlinson P, Sugarman ID. Complications with shunts in adults with spina bifida. BMJ 1995;311:286-287.
67. McGuire EJ, Woodside JR, Borden TA. Upper urinary tract deterioration with myelodysplasia and deutrusor hypertonia: a follow-up study. J Urol 1983;129:823-826.
68. Selzman AA, Elder JS, Mapstone TB. Urologic consequences of myelodysplasia and other congenital abnormalities of the spinal cord. Urol Clin North Am 1993;20:485-504.
69. Joseph DB, Bauer SB, Colodny AH, et al. Clean intermittent catheterization of infants with neurogenic bladder. Pediatrics 1989;84:78-82.
70. Chancellor MB, Anderson RU, Boone TB. Pharmacotherapy for neurogenic detrusor over activity. Am J Phys Med Rehabil 2006;85:536-545.
71. Aslan AR, Kogen BA. Conservative management in neurogenic bladder dysfunction. Curr Opin Urol 2002;12:473-477.
72. Mingin GC, Baskin LS. Surgical management of the neurogenic bladder and bowel. Int Braz J Urol 2003;29:53-61.
73. Silveri M, Capitanucci ML, Mosiello G, et al. Endoscopic treatment for urinary incontinence in children with a congenital neuropathic bladder. Br J Urol 1998;82:694-697.
74. Lemelle JL, Guillemin F, Aubert D, et al. A multicenter evaluation of urinary incontinence management and outcome in spina bifida. J Urol 2006;175:208-212.
75. Kassouf W, Capolicchio G, Berardinucci G, et al. Collagen injection for treatment of urinary incontinence in children. J Urol 2001;165:1666-1668.
76. Gonzalez R, Schimke CM. Strategies in urological reconstruction in myelomeningocele. Curr Opin Urol 2002;12:485-490.
77. Lemelle JL, Guillemin F, Aubert D, et al. A multicentre study of the management of disorders of defecation in patients with spina bifida. Neurogastroenterol Motil 2006;18:123-128.
78. Leibold S. A systemic approach to bowel continence for children with spina bifida. Eur J Pediatr Surg 1992;1(suppl 1):23-24.
79. King JC, Currie DM, Wright E. Bowel training in spina bifida: importance of education, patient compliance, age, and anal reflexes. Arch Phys Med Rehabil 1994;75:243-247.
80. Van Savage JG, Yohannes P. Laparoscopic antegrade continence enema in situ appendix procedure for refractory constipation and overflow fecal incontinence in children with spina bifida. J Urol 2000;164(3 pt 2):1084-1087.
81. Perez M, Lemelle JL, Barthelme H, et al. Bowel management with antegrade colonic enema using a Malone or Monti conduit - clinical results. Eur J Pediatr Surg 2001;11:315-318.
82. Incesu L. Chiari II malformation. Chiari II. E-Medicine. November 15, 2002. Accessed October 20, 2006.
83. Rintoul NE, Sutton LN, Hubbard AM, et al. A new look at myelomeningocele: functional level, vertebral level, shunting, and the implications for fetal intervention. Pediatrics 2002;109:409-413.
84. Oakeshott P, Hunt GM. Long-term outcome in open spina bifida. Br J Gen Pract 2003;53:632-636.
85. Buxton N, Jaspan T, Punt J. Treatment of Chiari malformation, syringomyelia and hydrocephalus by neuroendoscopic third ventriculostomy. Minim Invasive Neurosurg 2002;45:231-234.
86. Tuli S, Drake J, Lamberti-Pasculli M. Long-term outcome of hydrocephalus management in myelomeningoceles. Childs Nerv Syst 2003;19:286-291.
87. Hunt GM, Holmes AE. Factors relating to intelligence in treated cases of spina bifida cystica. Am J Dis Child 1976;130:823-827.
88. Vinchon M, Dhellemmes P. Cerebrospinal fluid shunt infection: risk factors and long-term follow-up. Childs Nerv Syst 2006;22:692-697.
89. Casey AT, Kimmings EJ, Kleinlugtebeld AD, et al. The long-term outlook for hydrocephalus in childhood. A ten-year cohort study of 155 patients. Pediatr Neurosurg 1997;27:63-70.
90. Pollack IF, Pang D, Kocoshis S, et al. Neurogenic dysphagia resulting from Chiari malformations. Neurosurgery 1992;30:709-719.
91. Pollak IF, Pang D, Albright AL, et al. Outcome following hindbrain decompression of symptomatic Chiari malformations in children previously treated with myelomeningocele closure and shunts. J Neurosurg 1992;77:881-888.
92. Choi SS, Tran LP, Zalzal GH. Airway abnormalities in patients with Arnold-Chiari malformation. Otolaryngol Head Neck Surg 1999;121:720-724.
93. Mathisen BA, Shepherd K. Oral-motor dysfunction and feeding problems in children with myelodysplasia. Pediatr Rehabil 1997;1:117-122.
94. Soare PL, Raimondi AJ. Intellectual and perceptual-motor characteristics of treated myelomeningocele children. Am J Dis Child 1977;131:199-204.
95. Yeates KO, Enrile BG, Loss N, et al. Verbal learning and memory in children with myelomeningocele. J Pediatr Psychol 1995;20:801-805.
96. Barnes M, Dennis M, Hetherington R. Reading and writing in young adults with spina bifida and hydrocephalus. J Int Neuropsychol Soc 2004;10:655-663.
97. Vacha B, Adams R. Language differences in young children with myelomeningocele and shunted hydrocephalus. Pediatr Neurosurg 2003;39:184-189.
98. Dennis M, Barnes M. Math and numeracy in young adults with spina bifida and hydrocephalus. Dev Neuropsychol 2002;21:141-155.
99. Dillon CM, Davis BE, Duguay S, et al. Longevity of patients born with myelomeningocele. Eur J Pediatr Surg 2000;10(suppl 1):33-34.
100. Atala A, Bauer SB, Soker S, et al. Tissue-engineered autologous bladders for patients needing cystoplasty. Lancet 2006;367:1241-1246.
101. Bruner JP, Tulipan N, Reed G, et al. Intrauterine repair of spina bifida: preoperative predictors of shunt-dependent hydrocephalus. Am J Obstet Gynecol 2004;190:1305-1312.
102. Tulipan N, Sutton LN, Bruner JP, et al. The effect of intrauterine myelomeningocele repair on the incidence of shunt-dependent hydrocephalus. Pediatr Neurosurg 2003;38:27-33.
103. Tubbs RS, Chambers MR, Smyth MD, et al. Late gestational intrauterine myelomeningocele repair does not improve lower extremity function. Pediatr Neurosurg 2003;38:128-132.
104. Deshpande DM, Kin YS, Martinez T, et al. Recovery from paralysis in adult rats using embryonic stem cells. Ann Neurol 2006;60:32-44.
105. Grumbles R, Casella GT, Rudinsky MJ, et al. The immunophilin ligand FK506, but not the P38 kinase inhibitor SB203580, improves function of adult rat muscle reinnervated from transplants of embryonic neurons. Neuroscience 2005;130:619-630.